Ethics Fixed Costs Tactics 
Harvard Business Review
MAY 2, 2013
These researchers opined that high prices are preventing patients from being treated, and they questioned the ethics of pharmaceutical companies. for instance, even insured patients pay an average of 20% of drug prices out-of-pocket, meaning these drugs can cost a patient $20,000 a year.
Harvard Business Review
OCTOBER 6, 2014
Successful companies are notoriously prone to pursuing tactical fixes rather than confronting strategic problems. They exhort their people to try harder, introduce overhead cost reduction programs, and reorganize – anything rather than admit that their strategy needs an overhaul. Ethics Global business Retail'
Expert insights. Personalized for you.
8 
Let's personalize your content